Could a cholesterol drug slow ovarian cancer? small study tests the idea.
Disease control
Completed
This early-phase study tested whether adding simvastatin, a common cholesterol-lowering drug, to standard chemotherapy could help control platinum-sensitive ovarian cancer. 18 women with recurrent disease took part. The main goal was to see if patients could stick with the simvas…
Phase: EARLY_PHASE1 • Sponsor: Marc Goodman • Aim: Disease control
Last updated May 08, 2026 12:02 UTC